6 min read
Don’t miss Paula Wun’s panel discussion on “Editing Considerations for Submission Documents” at the 5th Annual Regulatory Writing for Product Apporvals Conference.
Join Veristat and industry leaders in regulatory writing and submissions management at the upcoming 5th Annual Regulatory Writing for Product Approvals Conference to share and discuss the challenges of writing regulatory submissions in a continually changing regulatory environment.
Panel Discussion
On Thursday, April 28 at 10:40 AM, we invite you to join Paula Wun and an esteemed panel of industry experts will discuss the following:
EDITING CONSIDERATIONS
FOR SUBMISSION DOCUMENTS
Paula Wun, Senior Director, Medical Writing
Veristat
LEARNING OBJECTIVES
- Avoiding edits to verbatim data from source materials
- Designating a final authority decision maker
- Editorial comment specificity
- Clear text changes
- Data edits vs. writing style comments
- Develop editorial timelines for success
- Reducing reviewer fatigue
- Editorial checklist development
- Integration of edits into final submission
PANEL EXPERTS INCLUDE:
- Laura Sheppard, MBA, MA, Manager, Medical Writing, MALLINCKRODT PHARMACEUTICALS
- Becky Nuttall, Medical Writing Lead, EMD SERONO
- René Alvarez, Associate Director, Medical Writing, FIBROGEN
- Gretchen Griffin, MS, Director, Regulatory Writing Strategic Solutions and Operations, ABBVIE
- Leslie Lescale-Matys, Medical Writing Group Lead, SHIRE
We hope to see you at this exciting panel discussion.
Schedule a Meeting with Veristat
Veristat can offer you strategic guidance in planning for your regulatory submission, we provide representation at the agency meetings, and we provide the statistical as well as medical writing support to prepare the submission documents. We have over 20 years of experience helping clients prepare INDs, CTAs, NDAs, BLAs, and MAAs.
Schedule a time to speak with Paula or any of Veristat’s experts at the show about the challenges you are trying to overcome with your current or upcoming submission project.
Get the Latest News
Categories
- Regulatory Consulting (122)
- Regulatory Submissions (117)
- Clinical Trial Regulations (102)
- COVID-19 (46)
- Strategic Consulting (30)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Oncology (11)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Medical Writing (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
2 min read
ASCO Annual Meeting
Apr 23, 2025 Veristat Events
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...